Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors

NANot yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Hepatocellular Carcinoma (HCC)Gastro-Entero-Pancreatic Tumors (GEPs)
Interventions
DIAGNOSTIC_TEST

Single tracer PET/CT

Single tracer PET/CT for the HCC patients : one with \[18F\]FDG and one with \[18F\]F-choline Single tracer PET/CT for the GEP-NET patients : one with \[68Ga\]Ga-DOTATOC and one with \[18F\]FDG

DIAGNOSTIC_TEST

Multiplexed PET-CT

Multiplexed PET-CT for HCC patients : \[18F\]FDG + \[18F\]F-choline. Multiplexed PET-CT for GEP-NET patients : \[18F\]FDG + \[68Ga\]Ga-DOTATOC. The PET scans must be performed in any order and at least 24 hours apart.

Trial Locations (3)

Unknown

CHU Brest, Brest

Hopital Foch (AP-HP), Clichy

Chu Nantes, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT07178587 - Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors | Biotech Hunter | Biotech Hunter